Literature DB >> 8435747

Subsensitivity of lead-exposed rats to the accuracy-impairing and rate-altering effects of MK-801 on a multiple schedule of repeated learning and performance.

J Cohn1, D A Cory-Slechta.   

Abstract

Exposure to lead (Pb) has been reported to inhibit MK-801 binding and to alter other NMDA receptor complex-associated functions. These reported changes are provocative since both NMDA receptor antagonism and Pb exposure are know to impair learning processes. Whether the Pb-induced changes in NMDA function relate to the learning impairments associated with Pb exposure, however, has not been explored. The contention of this study was that if changes in NMDA function produced by Pb serve as the basis of Pb-associated learning impairments, then such changes should be of sufficient biological magnitude and clinical relevance to induce alterations in sensitivity at the level of the whole animal, i.e., changes in behavioral sensitivity to glutamatergic compounds. Thus, in this study, dose-effect curves of control and Pb-treated rats working on a multiple schedule of repeated learning (repeated acquisition, RA) and performance (P) were compared following acute administration of MK-801, the non-competitive NMDA antagonist. Based on the nature of the reported effects of Pb on NMDA systems, it was expected that the curves of Pb-exposed rats would be right-shifted relative to controls, if differential behavioral sensitivity was evident. Rats were chronically exposed to 0, 50 or 250 ppm Pb acetate in drinking water from weaning and trained on the multiple RA and P schedule beginning at 55 days old. The RA component required the rat to learn a new 3-member sequence of responses during each experimental session (center right left, RLC, CLR, RCL, or LRC), while the correct sequence of responses for the P component was constant across sessions (LCR), requiring performance of an already learned response. Acute administration of MK-801 (0.05-0.3 mg/k, i.p.) resulted in decrements in accuracy in both the RA and P components of the schedule, indicative of non-specific effects on behavior rather than selective effects on learning. The declines in accuracy during the RA component of the schedule were primarily the result of increased perseverative responding, i.e., repetitive responding on a single lever. Both the decline in RA accuracy and the increases in perseverative responding produced by MK-801 were attenuated by Pb exposure. Moreover, dose-effect curves relating MK-801 dose to changes in rates of responding were significantly shifted to the right in Pb-exposed rats relative to controls. Taken together, these data demonstrate a subsensitivity of Pb-exposed rats to both the accuracy-impairing and response rate-altering properties of MK-801.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435747     DOI: 10.1016/0006-8993(93)91375-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Chlordiazepoxide and dizocilpine, but not morphine, selectively impair acquisition under a novel repeated-acquisition and performance task in rats.

Authors:  R C Pitts; D R Buda; J R Keith; D T Cerutti; M Galizio
Journal:  Psychopharmacology (Berl)       Date:  2006-09-14       Impact factor: 4.530

2.  Examination of clozapine and haloperidol in improving ketamine-induced deficits in an incremental repeated acquisition procedure in BALB/c mice.

Authors:  Andrew Nathanael Shen; M Christopher Newland
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

3.  Lead exposure promotes translocation of protein kinase C activities in rat choroid plexus in vitro, but not in vivo.

Authors:  Q Zhao; V Slavkovich; W Zheng
Journal:  Toxicol Appl Pharmacol       Date:  1998-03       Impact factor: 4.219

4.  Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus.

Authors:  Peter J Winsauer; Patricia E Molina; Angela M Amedee; Catalin M Filipeanu; Robin R McGoey; Dana A Troxclair; Edith M Walker; Leslie L Birke; Curtis Vande Stouwe; Jessica M Howard; Stuart T Leonard; Joseph M Moerschbaecher; Peter B Lewis
Journal:  Exp Clin Psychopharmacol       Date:  2011-04       Impact factor: 3.157

5.  Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid: the role of the choroid plexus.

Authors:  W Zheng; H Shen; W S Blaner; Q Zhao; X Ren; J H Graziano
Journal:  Toxicol Appl Pharmacol       Date:  1996-08       Impact factor: 4.219

6.  Brain hemispheric differences in the neurochemical effects of lead, prenatal stress, and the combination and their amelioration by behavioral experience.

Authors:  Deborah A Cory-Slechta; Douglas Weston; Sue Liu; Joshua L Allen
Journal:  Toxicol Sci       Date:  2013-01-28       Impact factor: 4.849

7.  Developmental exposure to low level ambient ultrafine particle air pollution and cognitive dysfunction.

Authors:  D A Cory-Slechta; J L Allen; K Conrad; E Marvin; M Sobolewski
Journal:  Neurotoxicology       Date:  2017-12-13       Impact factor: 4.294

8.  Muscarinic cholinergic modulation of synaptic transmission and plasticity in rat hippocampus following chronic lead exposure.

Authors:  Mingliang Tang; Le Luo; Damiao Zhu; Ming Wang; Yunyun Luo; Huili Wang; Di-Yun Ruan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-21       Impact factor: 3.000

9.  Enhanced stimulus sequence-dependent repeated learning in male offspring after prenatal stress alone or in conjunction with lead exposure.

Authors:  D A Cory-Slechta; M B Virgolini; S Liu; D Weston
Journal:  Neurotoxicology       Date:  2012-07-13       Impact factor: 4.294

10.  Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.

Authors:  Magdalini Sachana; Alexandra Rolaki; Anna Bal-Price
Journal:  Toxicol Appl Pharmacol       Date:  2018-03-07       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.